Ardelyx (ARDX) Profit After Tax (2013 - 2026)
Ardelyx (ARDX) posted Profit After Tax of -$37.9 million for Q1 2026, down 9218.67% on a QoQ basis from -$407000.0 in Q4 2025, and up 7.91% year-over-year from -$35.1 million in Q1 2025.
Ardelyx (ARDX) Profit After Tax (2013 - 2026) Analysis & Trends
Ardelyx's Profit After Tax history runs 14 years deep, the most recent figure standing at -$37.9 million for Q1 2026.
- Quarterly Profit After Tax rose 7.91% year-over-year to -$37.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.3 million (down 8.4% YoY) and the FY2025 annual result came in at -$61.6 million, down 57.4% from the prior year.
- Profit After Tax was -$37.9 million for Q1 2026 at Ardelyx, down from -$407000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $10.8 million in Q4 2022 and bottomed at -$41.2 million in Q1 2025.
- A 5-year average of -$16.0 million and a median of -$19.1 million in 2025 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax jumped 129.81% — and 2023, when it tumbled 365.25%.
- Ardelyx's Profit After Tax stood at $10.8 million in 2022, then plunged by 365.25% to -$28.7 million in 2023, then jumped by 116.35% to $4.7 million in 2024, then sank by 108.69% to -$407000.0 in 2025, then plunged by 9218.67% to -$37.9 million in 2026.
- Business Quant data shows ARDX's Profit After Tax at -$37.9 million in Q1 2026, -$407000.0 in Q4 2025, and -$807000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Ardelyx | 1.24 Bn | 999.81 Mn | 89.66 Mn | -37.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -37.93 Mn |
| Dec 31, 2025 | -407,000.00 |
| Sep 30, 2025 | -807,000.00 |
| Jun 30, 2025 | -19.14 Mn |
| Mar 31, 2025 | -41.18 Mn |
| Dec 31, 2024 | 4.68 Mn |
| Sep 30, 2024 | -809,000.00 |
| Jun 30, 2024 | -16.45 Mn |
| Mar 31, 2024 | -26.52 Mn |
| Dec 31, 2023 | -28.66 Mn |
| Sep 30, 2023 | 6.64 Mn |
| Jun 30, 2023 | -17.12 Mn |
| Mar 31, 2023 | -26.74 Mn |
| Dec 31, 2022 | 10.80 Mn |
| Sep 30, 2022 | -22.90 Mn |
| Jun 30, 2022 | -26.94 Mn |
| Mar 31, 2022 | -28.15 Mn |
| Dec 31, 2021 | -36.23 Mn |
| Sep 30, 2021 | -43.59 Mn |
| Jun 30, 2021 | -45.19 Mn |